C-TYPE NATRIURETIC PEPTIDE (CNP) is one of a family of three related peptides that regulate fluid and electrolyte homeostasis (39) . Expression of the CNP gene (Nppc) is detected at highest levels in the central nervous system, female reproductive tissues, and bone (7, 20) . While CNP has vasodilatory action, circulating levels of CNP are low, and local autocrine and paracrine functions have been proposed (5) . Mice with a targeted Nppc null mutation die during the neonatal period, with severe dwarfism due to a failure of endochondral ossification (7) . One prominent role suggested for CNP is inhibition of myofibroblast function.
Myofibroblasts are cells that differentiate from fibroblasts after tissue injury and proliferate and gain smooth muscle cell features such as the expression of ␣-smooth muscle actin. Myofibroblasts are essential for wound matrix contraction and healing (46) and secrete high levels of collagen, fibronectin, and other extracellular matrix constituents. Myofibroblasts cease proliferation and disappear during normal wound healing (16) but can persist during chronic inflammation and injury. CNP may be part of the mechanisms by which myofibroblast activation is terminated. CNP inhibits hepatic myofibroblastic stellate cell (45) and fibroblast (6) proliferation, and fibroblasts express the CNP receptor, natriuretic peptide receptor B (NPR-B) (6) . CNP administration prevents neointimal fibrosis and arterial smooth muscle cell proliferation following balloon angioplasty (15, 47) . CNP inhibits basic fibroblast growth factor-, platelet-derived growth factor-, and epidermal growth factor-induced arterial smooth muscle cell proliferation (36) . Administration of CNP after renal glomerular injury reduces glomerular fibrosis and limits the proliferation of ␣-smooth muscle actinpositive mesangial cells (4) . These experiments demonstrate that exogenous CNP administration inhibits the proliferation and activation of smooth muscle cells and myofibroblasts and limits tissue fibrosis. However, expression and regulation of CNP gene (Nppc) expression after tissue injury have not been reported, and transcriptional regulation of Nppc has not been extensively studied (33) . Here, we examined Nppc expression in a well-characterized mouse model of renal tubulointerstitial fibrosis: unilateral ureteral obstruction (UUO) (30) .
Ligation of a single ureter results in extensive tubular cell damage, followed by macrophage influx and a fibrotic response (9, 10, 30) . By 1 wk, smooth muscle actin-positive interstitial fibroblasts are apparent. One source of interstitial fibroblasts is transdifferentiation from tubular epithelial cells (23) , which acquire expression of smooth muscle actin and other myofibroblast markers while still part of the tubular structure (31) . Fibrosis continues to progress, with increasing epithelial loss, accumulation of interstitial myofibroblasts, and extracellular matrix deposition. By 4 wk after ligation, the entire kidney exhibits extensive fibrosis. We report that Nppc expression was induced after UUO, and in identical cell populations to those in which Wnt4 is induced.
The Wnt genes code for secreted glycoproteins that act near their site of synthesis and are ligands for the frizzled family of receptors (34, 51) . Wnts regulate target gene transcription through multiple intracellular signaling pathways (29) , with the best-studied pathway involving an increase in the half-life of cytosolic ␤-catenin (2, 53). ␤-Catenin regulates gene transcription by translocating to the nucleus and interacting with transcription factors of the T cell factor/lymphoid enhancer binding factor (TCF/LEF) family (2, 3) . These factors are a subfamily of highmobility group factors that bind to specific DNA sequence elements (17, 50) . ␤-Catenin contains no DNA binding domain but a transcriptional activational domain. Wnt-4 is one member of the Wnt family that plays a critical role in genitourinary development. Wnt4 is activated in induced metanephric mesenchyme and is required for metanephric mesenchymal condensation (43) . Wnt-4 is expressed in the developing Mü llerian structures and is required for female development (48) . Wnt-4 is also expressed in adult reproductive tissues including uterus (28) , ovary (19) , and breast (14) . We and others have found that Wnt-4 is induced after renal injury leading to interstitial fibrosis (32, 44) . Wnt4 is first activated in the collecting duct epithelium after UUO and then in the accumulating interstitial myofibroblasts (44) . We report our finding that Nppc is induced in identical cell populations and at the same time as Wnt4 in the injured kidney and test the hypothesis that Wnt signaling regulates Nppc expression.
MATERIALS AND METHODS
Animals, ureteral obstruction, and tissue preparation. Approval was obtained from the Washington University Institutional Animal Care and Use Committee for all experiments involving animals. UUO was performed on anesthetized FVB/N and C57BL6/J mice of 6-7 wk of age and was accomplished by surgical cautery of the left renal ureter ϳ15 mm from the renal pelvis. The obstructed kidneys were harvested at 7 or 14 days after obstruction. Uninjured kidneys were harvested from 7-wk-old mice. Obstructed kidneys were frozen in OCT embedding medium for in situ hybridization. At least two obstructed kidneys were examined at each time point by in situ hybridization. Mouse embryos at day 17.5 of gestation (E17.5) were harvested after timed mating of 129SV/J mice.
RNA in situ hybridization. Wnt4 and Nppc mRNA transcripts were detected in murine samples by in situ hybridization of tissue sections. The template used to produce murine Wnt4 riboprobes was a gift from Andy McMahon (43) . The in situ Wnt4 antisense riboprobe spans nucleotides 803 to 366 (GenBank NM009523). The murine Nppc exon 2 was amplified by PCR from FVB/N mouse genomic DNA. Primers used to generate the Nppc template were 5Ј-AGGTC-CCGAGAACCCCG (sense) and 5Ј-ATGGAGCCGATCCG-GTCC (antisense) to generate a probe that complements nucleotides 1566-1721 (GenBank D28873). The PCR products were ligated into the pZero 2.0 bacterial plasmid (Invitrogen), and the sequence was verified. Radiolabeled antisense riboprobes for in situ hybridization were transcribed using linearized cDNA templates, [␣- 33 P]UTP (Amersham), and the Promega in vitro transcription system. In situ hybridization was performed utilizing 10-to 12-m sections of OCT-embedded kidneys as described (44) .
Transient transfection assays and cell culture. A transgene was constructed to include the Nppc sequence spanning nucleotides Ϫ1209 to ϩ56 relative to the start site of transcription (GenBank U62939, nucleotides 6-1271). The fifty-six transcribed nucleotides are outside the CNP open reading frame. The Nppc promoter sequence was amplified by PCR from FVB/N mouse genomic DNA, using primers 5Ј-TAATG-GTACCCATGTCCATCCCAGCAGTCTTCC (sense) and 5Ј-TGTGAAGCTTGGATTGCCAAGCGAGCACAG (antisense). The amplimer was digested with KpnI and HindIII, and ligated into pGL3 Basic vector (Promega) cut with the same enzymes. The resulting plasmid contains the Nppc sequences Ϫ1209 to ϩ56, including the transcriptional start site, linked to firefly luciferase cDNA and a transcriptional stop site. This transgene is termed Ϫ1209CNP. Modifications in the Nppc promoter region of Ϫ1209CNP detailed in Fig. 4A were introduced utilizing the Stratagene QuickChange Site-Directed Mutagenesis Kit according to the manufacturer's instructions. A murine Wnt-4 mammalian cell expression plasmid was purchased from Upstate Biotechnology and contains the Wnt-4 open reading frame fused with the murine Wnt1 transcript 5Ј-untranslated sequences to increase Wnt-4 production (53). The expression plasmid for full-length ␤-catenin plasmid in pCDNA3 was a gift from Stephen Byers (13) . The expression plasmid for full-length LEF-1 was a kind gift from Hans Clevers. All transfections included plasmid pRL-TK (Promega) as a control for transfection efficiency, and this plasmid expresses Renilla luciferase from a viral promoter.
RatB1a cells were cultured in DMEM plus 10% fetal bovine serum and nonessential amino acids. NRK52 E cells (ATCC) were cultured in DMEM adjusted to contain 1.5g/l sodium bicarbonate, 4 mM L-glutamine, 1 mM sodium pyruvate, and 5% fetal bovine serum. Transient transfections in RatB1a cells were performed in six-well plates with 8-10 ϫ 10 4 cells seeded/well 18-24 h before transfection. Transient transfection in NRK52E cells was done in six-well plates with 5 ϫ 10 4 cells seeded/well 18-24 h before transfection. All transient transfections were performed using the Superfect reagent (Qiagen) following procedures recommended by the manufacturer. Briefly, plasmid DNA was incubated with the Superfect reagent in DMEM for 5 min, after which the appropriate culture medium was added. This mixture was then added directly to cells from which the medium had been removed. Cells were covered with the transfection mixture for 2 h, after which the solution was replaced with the appropriate culture medium. Cell lysates were prepared for expression analysis between 36 and 48 h after removal of the transfection mixture. Firefly luciferase and Renilla luciferase reporter activities were determined using Dual Luciferase Assay System reagents and protocol (Promega). Luciferase activity was quantified in a luminometer immediately after cell lyses. The total amount of DNA transfected per well was kept constant in all transfections performed in a single experiment, utilizing appropriate "empty" expression plasmids. All assays were performed in triplicate for each condition in each experiment, and all cell transfection experiments were repeated at least twice.
Gel mobility shift assays. DNA for gel mobility shift assays (GMSAs) was produced by annealing two complementary single-strand synthetic oligonucleotides to produce 15-bp double-strand DNA (oligomers). An oligomer containing an optimal TCF/LEF binding site: 5Ј-CCCTTTGATCTTACC (26) was radiolabeled with [␥-32 P]ATP using polynucleotide kinase (Roche). GMSAs were performed as described (41) with the following exceptions: 25 ng of herring sperm DNA (Sigma) were included in all reactions instead of poly(dI . dC), and 375 ng of bovine serum albumin and a 128-fold molar excess of competitor oligonucleotide were included in each binding mixture. Three micrograms of nuclear extract from SW480 cells were used per reaction. The SW480 nuclear protein extracts were prepared by ultracentrifugation (11) . GMSA supershift assays included 0.75 g of anti-␤-catenin antibody (C19220, Transduction Laboratories) or 0.75 g of anti-vimentin antibody (V6630, Sigma) in each binding mixture. A 128-fold molar excess of various 15-bp oligomers was utilized to compete with the radiolabeled optimal TCF/ LEF binding site oligomer. These competitor oligomers were derived from the core and flanking sequences corresponding to each of the six potential Tcf/Lef sites in the Ϫ1209CNP transgene (see Fig. 5A ). Control competitions were performed using a mutated optimal TCF/LEF binding site oligomer, 5Ј-CCCTTTGGCCTTACC (26), as well as mutated oligomers corresponding to the modified Nppc Tcf/Lef sites (see Fig. 5A ).
RESULTS

Nppc is induced during renal tubulointerstitial disease in cells that express Wnt4.
Previous studies have defined an antifibrotic role for exogenous CNP (15, 47) , but Nppc expression during tissue fibrosis has not been defined. Therefore, we examined the expression pattern of Nppc during renal tubulointerstitial disease progression after UUO. Nppc mRNA was not detected by in situ hybridization in the uninjured kidneys of normal adult mice (Fig. 1A) . One week after UUO, strong Nppc expression was induced in the renal cortex (Fig. 1B) . High-power views revealed that expression was confined to collecting duct epithelial cells (Fig. 1 , C-E). This expression pattern is identical to that of Wnt4 after UUO (44) , where cortical expression in collecting duct epithelial cells was defined by the presence of aquaporin-3 (44) . In situ hybridization was performed to compare cellular localization of Wnt4 and Nppc transcripts. One week after UUO, Wnt4 was induced in the same collecting duct epithelial cells that Fig. 1 . Nppc is induced in renal tubules 1 wk after unilateral ureteral obstruction (UUO) and in the same cells in which Wnt4 is induced. RNA in situ hybridization was performed to determine whether Nppc expression is induced in the murine kidney after UUO. Sections were hybridized with a probe specific for Nppc, then counterstained with hematoxylin and eosin. Nppc mRNA is not detected in the adult uninjured kidney (A) but is induced in a punctate pattern in the cortex 1 wk after UUO (B). C: higher power view. Comparison of high-power darkfield view (D) and brightfield view (E) reveals induced Nppc expression is in collecting duct epithelial cells. Adjacent sections were hybridized with a specific probe for Wnt4 (F-I). A and F, B and G, C and H, D and I, and E and J: images of the same region in adjacent sections. Wnt4 is expressed in the collecting ducts found in the renal papillae (arrow in F) of an uninjured mouse kidney, and Wnt4 expression is induced in cortical regions in the 1-wk obstructed kidney (G). Nppc mRNA expression (B and C) and Wnt4 mRNA expression (G and H) are evident in strikingly similar patterns on adjacent sections (arrows and arrowheads in B and G). Arrows in C and H, renal tubules that express both Wnt4 and Nppc.
support Nppc expression (Fig. 1) . Nppc may be active in a greater number of the collecting duct epithelial cells than Wnt4, perhaps reflecting paracrine action of this secreted protein. In the uninjured kidney, Wnt4 was detected only in papillary collecting duct epithelial cells (Fig. 1F) , in contrast to Nppc, which was not detected. Wnt4 is initially activated in the collecting duct epithelium and later in the surrounding interstitial cells (44) . Two weeks after UUO, Wnt4 expression is evident in interstitial myofibroblasts (44) , and Nppc activation was observed in identical cell populations (Fig. 2) .
Wnt4 and Nppc are expressed in the same cell populations during renal development. The precise temporal and spatial coincidence of Wnt4 and Nppc induction after renal damage suggest the possibility that both genes may be induced during renal development at the time Wnt4 is activated. The expression pattern of Nppc mRNA was determined in murine embryonic kidneys at 17.5 days of gestation (E17.5) and compared with that of Wnt4. Nephrogenesis is initiated when groups of metanephric mesenchymal cells are induced by the ureteric bud to form condensates, which convert to tubular epithelial structures and mature into nephrons. Nephrogenesis in the developing kidney is an ongoing process, and the E17.5 kidney contains nephrons at all stages of nephrogenesis. Nppc mRNA (Fig. 3, D-F) was detected in the developing kidney in the nephrogenic zone. Wnt4 is expressed in these same cells (Fig. 3, A-C) , as well as in the central stromal cells where Nppc is not expressed (Fig. 3, A vs. D) . Wnt4 expression is initially induced in the condensing metanephric mesenchyme and remains active during metanephric condensation and conversion of condensates to renal epithelial vesicles and then comma-and S-shaped bodies. The earliest detectable Nppc expression during nephrogenesis occurs in metanephric mesenchymal condensates (Fig. 3F ) in which Wnt4 is also expressed (Fig. 3C) .
Wnt-4 transactivates the Nppc promoter in cultured cells. Wnt4 and Nppc are expressed in the same cells after renal damage, suggesting that Wnt-4 may regulate Nppc expression. Wnt-4 stabilizes cytosolic ␤-catenin in cultured RatB1a cells (44) and might activate Nppc through this pathway in these cells. The RatB1a cells resemble the renal myofibroblasts in which Wnt4 is activated in that they are nontransformed fibroblasts that express high levels of ␣-smooth muscle actin protein and collagen ␣ 1 (I) mRNA (data not shown). A transgene was constructed from murine Nppc nucleotides Ϫ1209 to ϩ56 relative to the start site of transcription linked to the firefly luciferase coding region as a reporter (Ϫ1209CNP). Transient transfections were performed in the presence and absence of a Wnt-4 expression construct to determine the effect of Wnt-4 on Nppc activity (Fig. 4) . Expression of Wnt-4 resulted in an increase in Nppc transgene activity.
TCF/LEF family factors bind to sites in the Nppc promoter. The possibility that Wnt-4 directly regulates Nppc expression was explored. The canonical Wnt signaling pathway regulates gene transcription through binding of ␤-catenin to TCF/LEF transcription factors, which recognize specific binding sites in the regulatory sequences of target genes. The start site of Nppc transcription has been defined for the murine gene (20) , and we located six potential TCF/LEF binding sites in the 1,200 nucleotides 5Ј to the transcriptional start. These sites differed from the consensus TCF/LEF binding sequence, 5Ј-CTTTGWW-3Ј (17, 49, 50) , by one or two residues (Fig. 5A) , although the core sequence of site 1 is identical to that of a proven TCF/LEF binding site in the c-jun regulatory region (27) . Thus Wnt-4 might directly activate Nppc transcription through the localization of ␤-catenin bound to a Tcf/Lef family member to the Nppc promoter.
GMSAs were performed to determine the relative affinity of the six potential Nppc Tcf/Lef sites for a TCF-␤-catenin complex. TCF-␤-catenin complexes were derived from SW480 cells, a human colonic carcinoma cell line with high levels of endogenous TCF-4 and ␤-catenin (27) . Nuclear extracts from SW480 cells form a ternary complex with TCF/LEF binding sequences, consisting of the oligomer, TCF, and ␤-catenin (27) . This complex formed with a radiolabeled oligonucleotide containing the optimal TCF/LEF sequence (Fig. 5A) , as indicated by a specific supershift with anti-␤-catenin antibody (Fig. 5B, complex B ). An additional, unidentified complex also formed (complex A). GMSA competitions were performed with a radiolabeled optimal TCF/LEF binding sequence oligomer and SW480 nuclear extracts to determine whether complex formation occurred with the Nppc sites. Specific complexes are identified by comparing GMSA that included a 128-fold molar excess of unlabeled optimal binding site oligomer (Fig. 5C, lane 1) and GMSA that included a 128-fold molar excess of an oligomer identical except for mutation of two residues to abolish TCF/ LEF factor binding (lane 2). Complete loss of complex B in the presence of excess oligomer with an authentic TCF/LEF binding site but not in the presence of excess oligomer without a functional TCF/LEF binding site indicates that this complex contains TCF/LEF factors.
GMSA competition assays were performed to determine the relative affinity of the complex containing TCF/LEF and ␤-catenin for the Nppc Tcf/Lef binding site oligomers (Fig. 5C ). Nonradiolabeled oligomers containing the Nppc Tcf/Lef site 1 sequence (Fig. 5C,  lane 3) or site 2 sequence (lane 5) competed as well as the optimal TCF/LEF binding site oligomer (lane 1) for the complex containing TCF/LEF and ␤-catenin ( lane  2, complex B) . The nonradiolabeled oligomers containing mutated Nppc Tcf/Lef site 1 sequence (lane 4) or mutated Nppc Tcf/Lef site 2 sequence (lane 6) demonstrated a significantly lower affinity for the complex containing TCF/LEF and ␤-catenin compared with the oligomers containing the native sequences of these Nppc Tcf/Lef sites. Thus Nppc Tcf/Lef sites 1 and 2 interact in vitro with a nuclear protein complex containing TCF/LEF and ␤-catenin with similar affinity to that of an optimal site. Nppc sites 3-6 demonstrated significantly less affinity than the optimal site for complex formation. sites was determined utilizing transient transfection assays in cultured cells. Transfections were performed in cultured RatB1a cells, which have properties of myofibroblasts, and also a rat kidney tubular epithelial cell line, NRK52E (8) . The renal epithelial cell line and myofibroblast cell line were chosen for the transfection assays because Wnt4 and Nppc are initially activated in the renal epithelial cells (Fig. 1) and then in interstitial myofibroblasts (Fig. 2) . The ability of Wnt signaling pathway components to transactivate the Ϫ1209CNP transgene was tested in the cultured cell lines. Both ␤-catenin and LEF-1 transactivated the Ϫ1209CNP transgene in both cell lines (Fig. 6, A  and B) .
LEF-1 transactivates the Nppc promoter through interaction with
Transactivation assays were performed with Ϫ1209CNP transgenes in which the TCF/LEF sites were destroyed by site-directed mutagenesis to determine whether LEF-1 transactivation of Ϫ1209CNP is mediated through the six TCF/LEF elements. LEF-1 transactivation was compared among the native transgene, a transgene with sites 1 and 2 mutagenized, and a transgene with all six sites mutagenized. Sites 1 and 2 demonstrated significantly greater Tcf/Lef binding in the GMSA than the other four sites. Mutagenesis was accomplished with a 2-bp change to the core TCF/LEF consensus sequence of each site, as shown in Fig. 5A . LEF-1 activation of Ϫ1209CNP was significantly reduced in both cell lines by modification of Tcf/Lef sites 1 and 2 (Fig. 6, C and D) compared with the native Ϫ1209CNP transgene. Mutagenesis of all six sites did not result in a further decrease in Ϫ1209CNP transactivation by LEF-1 (Fig. 6, C and D) . These results indicate sites 1 and 2 bind Tcf-Lef complexes in vitro and mediate Nppc transgene activation by LEF-1 in cells.
To determine whether Wnt-4 activation of the Nppc transgene was dependent on intact Tcf/Lef binding sites, Wnt-4 activation of the native transgene and the transgene with Tcf/Lef sites 1 and 2 mutagenized was tested in RatB1a cells (Fig. 6E) . Wnt-4 significantly activated the native transgene but not the mutagenized transgene. The mutagenized transgene exhibited a decreased transcriptional activity in the absence of Wnt-4 compared with the native transgene, consistent with constitutive activity of the ␤-catenin and Tcf-Lef pathways in these cells. We have detected cytosolic ␤-catenin in these cells (44) , and the artificial ␤-catenin/TCF/LEF target gene TOPFLASH (25) exhibits twice the activity in RatBa1 cells as an identical gene with mutagenized TCF/LEF binding sites (data not shown). We were unable to demonstrate Wnt activation of any gene in NRK52E cells, indicating that these cells may have a defect in Wnt signaling components such as the receptor.
DISCUSSION
We have identified Nppc as a gene regulated by Wnt-4, LEF-1, and ␤-catenin. The cell transfection assays and GMSAs demonstrate that the Wnt-␤-catenin-LEF-1 signaling pathway directly stimulates Nppc through interaction with Tcf/Lef sites 1 and 2. Mutagenesis of Tcf/Lef sites 1 and 2 decreased but did not eliminate Ϫ1209CNP transactivation by LEF-1, but no additional loss of transactivation occurred when all six potential Tcf/Lef sites were mutagenized. These results are similar to those reported for TCF/LEF/␤-catenin regulation of Axin2, where the promoter contains eight potential Tcf/Lef sites and mutation of all sites together reduces but does not eliminate ␤-catenin activation of an Axin2 transgene (24) . TCF/LEF family members bind to DNA and achieve transcriptional regulation of target genes through interaction with coactivators such as ␤-catenin or corepressors such as groucho homologues (2) . We observed that LEF-1 alone achieves significant activation of the Nppc transgene in both cell lines, in agreement with previous studies showing that overexpression of LEF-1 can mimic Wnt signaling (3, 38) . The Nppc Tcf/Lef element binds TCF4 and is activated by LEF-1, but the identity of Tcf/Lef family members in the kidney and their activity during injury and repair remain unknown. This pathway plays a critical role in nephrogenesis, where Wnt-4 signaling is required, and possibly in nephrogenic differentiation because PKD1 is a target of Wnt ␤-catenin/ TCF/LEF signaling.
We have linked the induction of Nppc expression to Wnt4 expression in renal development and after renal injury, in that Nppc is expressed in cells that also express Wnt4. Wnt4 is activated in the collecting duct epithelium and later in the surrounding interstitial cells (44) after renal damage, and Nppc was induced in identical cell populations and at the same time as Wnt4. These results are consistent with regulation of Nppc transcription by Wnt4, because Wnts bind tightly to the cell surface and are believed to act in an autocrine or paracrine fashion (34) . Other Wnts are also present in the kidney and could potentially regulate Nppc expression through the same signaling pathway (32) in addition to or in conjunction with Wnt-4.
Nppc activation is not detected in the papillary epithelial cells that express Wnt4 in the normal kidney, implying that Wnt-4 is not sufficient for Nppc activation in the papillary collecting ducts. Other regulators present in the wounded kidney may be required in addition to Wnt4 to activate Nppc. It is also possible that inhibitors of Wnt signaling are active in the normal kidney to suppress Nppc activation. A role for CNP in wound healing is consistent with activation that is dependent on mediators present only during wounding. Renal damage initiated by numerous processes results in Wnt4 activation throughout the collecting ducts (44), suggesting a role for Wnt-4 in collecting duct function. Wnt-4 regulation of Nppc provides precedent for involvement of Wnt-4 in regulating other molecules that control electrolyte balance. It would be of interest to screen for Wnt-inducible genes in papillary collecting duct epithelial cells to detect other potential targets, because some of these may be active in the normal papillary collecting ducts. Wnt-4 may regulate genes in the normal kidney distinct from those it regulates in response to renal injury. Similarly, Wnt4 expression in the normal papillary collecting ducts may be regulated by a mechanism different from the one that activates Wnt4 expression in response to collecting duct injury. Alternatively, the most distal collecting ducts in the normal kidney may be subject to a greater degree of stress than the rest of the collecting ducts, and Wnt4 expression may be a response to recurring mild injuries in these cells.
Nppc induction after injury suggests the presence of a pathway for termination of wound healing and myofibroblast activation after injury. Extensive investigation has established that exogenous CNP inhibits myofibroblast proliferation and activation (6, 45) , as well as prevents neointimal fibrosis after arterial injuries and glomerular fibrosis after renal injuries (4, 15, 47) . Renal fibrosis induced by UUO does not resolve due to the sustained and continuing injury caused by permanent ureteral ligation, but Nppc induction may represent an attempt to control the ongoing fibrosis. Furthermore, CNP produced in the kidney may circulate and contribute to the vascular phenotype that accompanies chronic renal disease. CNP levels are increased in the plasma of diabetic rats (40) and humans with chronic renal failure (22) . It would be of interest to test the requirement for Nppc in termination of myofibroblast activity after injury. This could be accomplished by comparing the extent of renal interstitial cell proliferation and amount of extracellular matrix accumulation after renal injury in normal mice to that in Nppc null mice rescued by CNP transgene expression in the bone (7) . The potential of CNP to modify fibrotic progression could be determined by performing similar experiments in mice treated with exogenous CNP (4).
A wider role for CNP as a mediator of Wnt-4 action is suggested by coincident expression of the two genes at other sites. Both Wnt4 and Nppc are expressed in the growth plate of bone. Proliferating chondrocytes normally exit the cell cycle during endochondral ossification to become prehypertrophic chondrocytes and then hypertrophic chondrocytes. Misexpression of Wnt-4 in chick embryo limb cartilage elements accelerates cell cycle exit of proliferating chondrocytes, possibly through activation of the ␤-catenin-LEF-1 signal transduction pathway (18) . Nppc mRNA is expressed in the proliferating chondrocytes and prehypertrophic chondrocytes (7) . Nppc Ϫ/Ϫ mice are defective in longitudinal bone growth due to a reduction in the rate of maturation of proliferating chondrocytes to hypertrophic chondrocytes (7). These observations are consistent with Wnt-4 regulating Nppc expression during chondrocyte maturation. It will be of interest to determine whether the misexpression of Wnt-4 in the chick cartilage elements results in increased or premature Nppc expression in proliferating chondrocytes. Wnt4 and Nppc are both expressed in the endometrium, and levels of both are coincidently regulated throughout the murine estrus cycle (1, 28, 37) . It has been suggested that CNP may mediate the tissue remodeling that occurs in both wound healing and the estrus cycle (20) . CNP might also mediate similar remodeling during renal development, where conversion of metanephric mesenchyme to epithelium is dependent on Wnt-4.
CNP may inhibit cellular proliferation through elevated cGMP signaling. Binding of CNP to its receptor activates the NPR-B intracellular guanylyl cyclase domain, resulting in increased cytosolic cGMP. Increased cGMP activates intracellular signaling pathways that regulate cellular proliferation. Mice with a null mutation in the cGMP-dependent protein kinase II gene exhibit defective chondrocyte maturation (35), a finding consistent with the phenotype of the Nppc null mutation. In addition, CNP inhibits cultured hepatic myofibroblast cell proliferation through a mechanism dependent on protein kinase G activation by cGMP (45) . CNP may also inhibit cellular proliferation through cGMP inhibition of the MAP kinase pathway to limit growth factor stimulation of cell proliferation (6, 45) . Another mechanism by which CNP may inhibit cellular proliferation is through activation of the growth arrest-specific homeobox gene Gax and cyclindependent kinase inhibitor p21 (12, 52) . CNP induces Gax expression in smooth muscle cells (52) , and overexpression of Gax inhibits cell proliferation in a p21-dependent manner (42) . Mice with a null mutation in the p21 gene have increased renal interstitial cell proliferation and higher numbers of interstitial myofibroblasts 3 days after UUO compared with that of wildtype mice (21) . It is possible that Nppc activation after renal injury may limit renal interstitial cell proliferation and the extent of fibrosis through activation of p21.
